T Scientific Co.Ltd (057680) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of T Scientific Co.Ltd stock KRW 1,034, price KRW 1,269, that is 18.5% below the price, quality 49 out of 100. Rating: overvalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 1,269 KRW – 29,950 KRW · fair‑value band 700.26 KRW – 1,740 KRW · the 1,269 KRW price screens above the 1,034 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow T Scientific Co.Ltd in your weekly email
Every Wednesday you see whether T Scientific Co.Ltd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
T Scientific Co., Ltd. engages in wired/mobile communication and broadcast business in Korea and internationally.
Show moreShow less
The company offers mobile broadcast service, which is enabled by Cell Broadcasting Service technology; Smart DMB that is an integrated DMB application, which enables customers to watch TV or radio with DMB-embedded smartphones, as well as various value added services through telecommunication network in the same screen; and Smart Health Care applications.
It is also involved in platform business. The company was founded in 1998 and is based in Seoul, South Korea.
Stock analysis
T Scientific Co.Ltd (057680) currently trades at 1,269 KRW, while our model-based Fair Value estimate is 1,034 KRW, 19% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 3,371 KRW per share, and 1 of the 13 models we run sit above the 1,269 KRW price.
Bear case: the Multiples group reads lowest at 118.15 KRW, and 12 of the 13 models stay below the price. Data coverage for this calculation is low.
Scenario range: 700.26 KRW (bear) to 1,740 KRW (bull), the price of 1,269 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
T Scientific Co.Ltd reported revenue of 36.4B KRW in FY2025 versus 10.1B KRW in FY2021, a compound +37.8%/yr. Reported net income was −1.3B KRW in FY2025.
Key figures
Market cap 21.2B KRW (≈ $15.7M) Micro · P/S ratio 0.61 · Net margin −34.4% · Return on equity −876% · Return on assets (EBIT) −4.9% (5-year average) · Operating margin −23.0% · Revenue (TTM) 35.0B KRW · Revenue growth (YoY) −17.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).
What moves the price
The share trades about 73% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at −2% fair-value upside, at −19%, 057680 screens richer than that median.
Fair Value models
Bear700.26 KRWFair Value 1,034 KRWBull1,740 KRW
Price 1,269 KRW · Downside -18.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.48/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−15.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+61.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.7%
Start year 2020 (pandemic). Over 10 years: −0.2% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
24.1% (2019) → −20.8% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+21.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about +19.2% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software & IT Services · 33 stocks
Beats the industry median on 3/10 measures
Overall it trails its industry peers.
Valuation
Quality Score49 · Below median
Fair Value upside−18.5% · Below median
Profitability
Return on assets−0.6% · Below median
Net margin (12 months)−34.4% · Bottom 25%
Operating margin (12 months)−23.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−17.3% · Below median
Balance sheet
Debt / equity0.03× · Below median
Valuation Multiplesvs Software & IT Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is T Scientific Co.Ltd (057680) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 1,034 KRW versus a price of 1,269 KRW, about 19% lower (overvalued).
What is the fair value of 057680?
Our model-based fair value for T Scientific Co.Ltd is 1,034 KRW (as of Nov 8, 2026), built from audited fundamentals. The current price: 1,269 KRW.
What is the quality score of 057680?
T Scientific Co.Ltd has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for T Scientific Co.Ltd (057680)?
Our model-based price target is the fair value of 1,034 KRW (as of Nov 8, 2026) from 13 valuation models. Cautious scenario 700.26 KRW, optimistic scenario 1,740 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the T Scientific Co.Ltd stock forecast for 2026?
Our models put fair value at 1,034 KRW, about 19% lower versus a price of 1,269 KRW (overvalued). Cautious scenario 700.26 KRW, optimistic scenario 1,740 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of T Scientific Co.Ltd (057680)?
T Scientific Co.Ltd reported trailing-twelve-month revenue of about 35.0B KRW (latest available figure, as of Nov 8, 2026).
What growth is priced into T Scientific Co.Ltd (057680)?
For today's price to be fair in a discounted-cash-flow model, T Scientific Co.Ltd would have to grow free cash flow by +21.6 % per year for five years (discount rate 10.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +30.7 % per year. Calculated on free cash flow for fiscal year 2025. Over the last twelve months it was negative, so the figure above is uncertain. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 057680 use?
Our models discount T Scientific Co.Ltd at 10.8 %: a base by market capitalisation (nano), damped by beta 1.25, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For T Scientific Co.Ltd that is +21.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.8 %) and the same formula as our fair value.
How much growth has T Scientific Co.Ltd (057680) delivered so far?
Over the past 5 years revenue at T Scientific Co.Ltd grew +30.7 % a year. The price currently implies free-cash-flow growth of +21.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of T Scientific Co.Ltd (057680) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into T Scientific Co.Ltd (+21.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of T Scientific Co.Ltd (057680)?
The free-cash-flow yield on the price is 3.44 % in the last fiscal year (free cash flow was negative over the last twelve months): that much free cash flow T Scientific Co.Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of T Scientific Co.Ltd (057680)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For T Scientific Co.Ltd it is 1,034 KRW per share (as of Nov 8, 2026), against a price of 1,269 KRW. It is the blended result of 13 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit).
Is T Scientific Co.Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 057680 trades above its calculated fair value: price 1,269 KRW, fair value 1,034 KRW, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 057680?
No. The price is what the market pays today (1,269 KRW); the fair value is what the company's own numbers justify (1,034 KRW). For T Scientific Co.Ltd the two are 235.15 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is T Scientific Co.Ltd worth?
The market values T Scientific Co.Ltd at about 21.2B KRW (market capitalisation, as of Nov 8, 2026). Per share that is 1,269 KRW; our models calculate a fair value of 1,034 KRW per share.
What do the bullish and bearish scenarios say about 057680?
Our models span a range for T Scientific Co.Ltd: cautious scenario 700.26 KRW, base 1,034 KRW, optimistic 1,740 KRW per share (as of Nov 8, 2026, price 1,269 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of T Scientific Co.Ltd (057680)?
Balance-sheet figures for T Scientific Co.Ltd (as of Nov 8, 2026): debt of 0.03 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 057680 from its 52-week high?
T Scientific Co.Ltd trades at 1,269 KRW, about 73% below its 52-week high of 4,625 KRW and at the low of 1,269 KRW (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 1,034 KRW is for.
Which stocks are comparable to T Scientific Co.Ltd?
From the same area (Technology) we also value Gabia Inc, KINX, Inc, Wemade Co, AfreecaTV Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is T Scientific Co.Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price 1,269 KRW, calculated fair value 1,034 KRW (−19%), Quality Score 49/100, from 13 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 057680 calculated?
We run T Scientific Co.Ltd through 13 models from 6 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit. Every model gets the same audited fundamentals; the fair value of 1,034 KRW builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. T Scientific Co.Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of T Scientific Co.Ltd (057680)?
The closing price on Nov 6, 2026 was 1,269 KRW. Our model-based fair value is 1,034 KRW, about 19% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with T Scientific Co.Ltd right now?
Weak quality (49/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (700.26 KRW to 1,740 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of T Scientific Co.Ltd
How large is the market capitalisation of T Scientific Co.Ltd (057680)?
The market capitalisation of T Scientific Co.Ltd is 21.2B KRW (≈ $15.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of T Scientific Co.Ltd (057680)?
The price-to-sales ratio of T Scientific Co.Ltd is 0.61 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of T Scientific Co.Ltd (057680)?
The net margin of T Scientific Co.Ltd is −34.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of T Scientific Co.Ltd (057680)?
The return on equity (ROE) of T Scientific Co.Ltd is −876% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of T Scientific Co.Ltd (057680)?
On an EBIT basis the return on assets of T Scientific Co.Ltd is −4.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of T Scientific Co.Ltd (057680)?
The operating margin of T Scientific Co.Ltd is −23.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at T Scientific Co.Ltd (057680)?
Revenue at T Scientific Co.Ltd is growing −17.3% versus a year earlier (3y avg +61.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does T Scientific Co.Ltd (057680) carry?
The net debt of T Scientific Co.Ltd is 2.4B KRW (fiscal year 2024, ≈ 3.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch T Scientific Co.Ltd in the live analysis
One click puts T Scientific Co.Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026